AAP
Previous Next
AAP

Agencies    AAP


Australian Associated Press

Australian Associated Press was formed in 1935 as the national news agency of Australia. Today AAP is Australia's largest independent originator and aggregator of news and information, serving the media, government, business and financial markets.

AAP's media intelligence division; Medianet, leverages this foothold in the Australian media to distribute press releases and media statements nationwide.

AAP Medianet is the most reputable press release distribution service in Australia offering direct access to newsrooms and journalists with publishing to the AAP Newswire and to the Medianet website, dissemination via email, SMS and other online publishing options. Medianet also offers an industry-unique news release review service where-by our editorial team review and score press releases for their newsworthiness for the media industry.

Internationally, as an AsiaNet member, Medianet communicates directly with 33 countries across the Asia-Pacific region and beyond, through its exclusive links with leading news release organisations in Europe and the United States.

AAP Medianet

Address:
AAP Medianet (Sydney office)
3 Rider Boulevard
Rhodes NSW 2138
Australia

AAP Medianet (Melbourne office)
3/250 Victoria Parade
East Melbourne VIC 3003
Australia

Contact:
Medianet International
+61 2 9322 8686
medianet@aap.com.au

General email:
medianetsales@aap.com.au

Website:
www.medianet.com.au
Latest Press Release
Photo File: Cancer patient Robert Simpson, who is being treated for non-Hodgkin Lymphoma, is tended to by a nurse in a cancer ward at the Princess Alexandra Hospital in Brisbane, Wednesday, April 23, 2014. (AAP Image)

Photo File: Cancer patient Robert Simpson, who is being treated for non-Hodgkin Lymphoma, is tended to by a nurse in a cancer ward at the Princess Alexandra Hospital in Brisbane, Wednesday, April 23, 2014. (AAP Image)

FED: Hodgkin's patients to get Keytruda on PBS

Date: Sun 15 Apr 2018


Breakthrough cancer drug Keytruda will become available to patients with a form of Hodgkin lymphoma in May on the PBS at affordable prices.

The cancer drug would have cost $200,000 but the government's move to list in on the Pharmaceutical Benefits Scheme means patients won't pay more than $39.50 a script.

The drug has been available on the PBS for advanced melanoma but not blood cancers.

Immunotherapy drug Keytruda is often the last hope for patients who haven't responded to chemotherapy, News Corp Australia reports.

Hodgkin lymphoma is the cancer of the lymphatic system.

Source: AAP Australian General News